GH Secretagogue Research Standards
Growth hormone secretagogues (GHS) and growth hormone releasing hormone (GHRH) analogs stimulate pituitary GH release through two distinct receptor pathways: GHRH-R (stimulated by CJC-1295, Sermorelin, Tesamorelin) and GHS-R/ghrelin receptors (stimulated by Ipamorelin, Hexarelin, GHRP-2, GHRP-6). Because these pathways are synergistic, combination protocols are common in research - but they require independent calculation for each compound.
Timing precision matters for GH peptides. Most GHRH analogs are studied at dosing windows that align with the body's natural GH pulsatility - typically before sleep or in a fasted state. Getting the draw volume right on a 100 µg Ipamorelin dose (which is only 4 units on a standard insulin syringe at 2.5 mg/mL) requires exact math that this hub provides for every compound.
All dosing data is cross-referenced against independent analytical lab results. For research use only.